Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine.
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Fatty acids are known to increase the severity of injury during acute myocardial ischemia. In this study, we determined the effects of a carnitine palmitoyltransferase I inhibitor, ethyl 2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate (Etomoxir) on reperfusion recovery of fatty acid perfused hearts. Following a 25-minute period of global ischemia, isolated working hearts reperfused with 1.2 mM palmitate, 11 mM glucose exhibited depressed function compared to hearts perfused with 11 mM glucose alone. A low dose of Etomoxir (10(-9) M) decreased long chain acylcarnitine and long chain acyl-coenzyme A (CoA) levels but did not prevent depressed function. In contrast, a high dose of Etomoxir (10(-6) M) prevented the palmitate-induced depression of function but did not decrease myocardial long chain acylcarnitine or long chain acyl-CoA levels. At this high dose of Etomoxir, oxygen consumption per unit work was decreased during reperfusion recovery, and ATP and creatine-phosphate levels were significantly higher after reperfusion. In aerobic hearts not subjected to ischemia, Etomoxir (10(-6) M) increased glucose oxidation both in the presence and absence of palmitate, while 10(-9) M Etomoxir had no effect. In these aerobic hearts, only the low dose of Etomoxir decreased long chain acylcarnitine and long chain acyl-CoA levels. These data demonstrate that Etomoxir (10(-6) M) increases functional recovery of fatty acid perfused ischemic hearts. This protection is unrelated to changes in levels of long chain acylcarnitines but may be due to increased glucose use by the reperfused heart, resulting in decreased oxygen consumption per unit work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 1×
“Etomoxir is of potential interest in the treatment of diabetes since inhibition of fatty acid oxidation should increase glucose utilization and decrease gluconeogenesis.(21)-(22) By inhibiting fatty acid oxidation, fatty acid-induced inhibition of glycolysis may be overcome, thereby increasing glucose utilization.”
BackgroundRelationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle
Neely, J. R., & Morgan, H. E. (1974) · Annual Review of Physiology · doi:10.1146/annurev.ph.36.030174.002213 · Cited by 1,261
McGarry, J. D., & Foster, D. W. (1976) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36985-6 · Cited by 523
RELATION BETWEEN SERUM-FREE-FATTY-ACIDS AND ARRHYTHMIAS AND DEATH AFTER ACUTE MYOCARDIAL INFARCTION
OLIVER, M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92163-6 · Cited by 515
Coenzyme A and carnitine distribution in normal and ischemic hearts.
Idell-Wenger, J. A., Grotyohann, L. W., & Neely, J. R. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34721-x · Cited by 475
Control of fatty acid metabolism in ischemic and hypoxic hearts.
Whitmer, J. T., Idell-Wenger, J. A., Rovetto, M. J., & Neely, J. R. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34720-8 · Cited by 325
Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction
Opie, L. H. (1975) · The American Journal of Cardiology · doi:10.1016/0002-9149(75)90086-7 · Cited by 304
Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium
Shug, A., Shrago, E., Bittar, N., Folts, J., & Koke (1975) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1975.228.3.689 · Cited by 263
Adams, R. J., Cohen, D. W., Gupte, S., Johnson, J. D., Wallick, E. T., Wang, T., & Schwartz, A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86329-9 · Cited by 169
Influence of free fatty acids on myocardial oxygen consumption and ischemic injury
Vik-Mo, H., & Mjøs, O. D. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90621-4 · Cited by 167
SERUM-FREE-FATTY-ACIDS AFTER ACUTE MYOCARDIAL INFARCTION AND CEREBRAL VASCULAR OCCLUSION
Kurien, V. A., & Oliver, M. F. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92420-2 · Cited by 155
Opie, L. H., Owen, P., & Riemersma, R. A. (1973) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1973.tb02210.x · Cited by 135
Metabolic Response during Impending Myocardial Infarction
Oliver, M. F. (1972) · Circulation · doi:10.1161/01.cir.45.2.491 · Cited by 104
Lopaschuk, G. D., Katz, S., & McNeill, J. H. (1983) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y83-068 · Cited by 94
Self-citationAllison, S. P., Chamberlain, M. J., & Hinton, P. (1969) · BMJ · doi:10.1136/bmj.4.5686.776 · Cited by 93
Substrate use in ischemic and reperfused canine myocardium: quantitative considerations
Myears, D. W., Sobel, B. E., & Bergmann, S. R. (1987) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1987.253.1.h107 · Cited by 88
Metabolic responses of the heart in acute myocardial infarction in man
Mueller, H. S., & Ayres, S. M. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90929-3 · Cited by 80
The effects of 2{5(4-chlorophenyl) pentyl}oxirane-2-carbonyl-CoA on mitochondrial oxidations
Turnbull, D. M., Bartlett, K., Younan, S. I. M., & Sherratt, H. S. A. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90243-0 · Cited by 63
Metabolism of palmitate in isolated working hearts from spontaneously diabetic "BB" Wistar rats.
Lopaschuk, G. D., & Tsang, H. (1987) · Circulation Research · doi:10.1161/01.res.61.6.853 · Cited by 57
Self-citationMOLAPARASTSALESS, F., Liedtke, A., Nellis, S. H., Whitesell, L., Eggleston, A. M., & KNEELAND, L. (1987) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(87)80402-9 · Cited by 46
Rosen, P., & Reinauer, H. (1984) · Metabolism · doi:10.1016/0026-0495(84)90132-x · Cited by 45
Effects of POCA on metabolism and function in the ischemic rat heart
Paulson, D. J., Noonan, J. J., Ward, K. M., Stanley, H. M., SHERRATT, A., & Shug, A. L. (1986) · Basic Research in Cardiology · doi:10.1007/bf01907382 · Cited by 34
Cited by
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Self-citationMitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development
van der Windt, G. J. W., Everts, B., Chang, C.-H., Curtis, J. D., Freitas, T. C., Amiel, E., Pearce, E. J., & Pearce, E. L. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.007 · Cited by 1,540
“To determine whether the enhanced SRC in IL-15 memory T cells depends on FAO, we exposed IL-15 memory T cells to the CPT1 inhibitor etomoxir, which blocks mitochondrial FAO (Deberardinis et al., 2006; Lopaschuk et al., 1988).”
BackgroundStanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00245-3 · Cited by 606
Cellular fatty acid-binding proteins: Their function and physiological significance
Glatz, J. F. C., & van der Vusse, G. J. (1996) · Progress in Lipid Research · doi:10.1016/s0163-7827(96)00006-9 · Cited by 566
Kudo, N., Barr, A. J., Barr, R. L., Desai, S., & Lopaschuk, G. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17513 · Cited by 564
Self-citation
Metadata
- Authors
- Lopaschuk, G. D., Wall, S. R., Olley, P. M., & Davies, N. J.
- Venue
- Circulation Research
- Published
- 1988-12
- Volume
- 63
- Issue
- 6
- Pages
- 1036-1043
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2101881994
- Cited by
- 284
- References
- 22
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.